Forensic · ORMP
ORAMED PHARMACEUTICALS INC.
No signals triggered in our 36-month window. Most stable large-caps look like this. The $9 report still gets you the full chronology of every filing scanned + a clean-record audit trail.
Bear case preview · free
ORMP triggered zero forensic red flags across a 36-month lookback: no bankruptcy filings, accounting restatements, exchange delistings, C-suite departures, equity dilution events, or disclosed cyber incidents materialized in the dataset. The clean scan reflects either genuine operational stability or absence of public disclosure events rather than underlying asset quality. Score elevation or depression in the next 30-90 days would depend on filing material adverse changes, executive turnover, or delisting notices that surface in SEC filings or exchange notices.
↑ That's free. The $9 report goes deeper: every filing cited by accession number, 36-month chronology, what to watch next.
What we checked
✓ Red flags · 36mo
0 8-K events (bankruptcy, delisting, restatement, auditor, officer)
✓ Cyber · 12mo
0 Item 1.05 disclosures + buried-cyber scan
✓ Dilution · 24mo
0 S-3 + 424B5 filings
✓ Buried events
Item 8.01 sections classified for hidden material disclosures
$9
· one-time · emailed in under a minute
The full bear case on ORMP
Plain-English brief. Every signal cited to the exact SEC filing. 36-month chronology. What changes next.
✓ No-signals refund: if the algorithm finds zero red flags on your ticker, reply "refund" and I send the $9 back same day. No questions.
Not ready to buy? Get a free preview by email instead
We'll email you the top 3 signals on ORMP + a discount code for the full report. No subscription, no spam.
Score another ticker
Not investment advice. Every signal grounded in a specific SEC filing. Companies may respond via info@filingfirehose.com.